Clinical Trials Browser

Phase 1/2 × Not yet recruiting × Locally Advanced or Metastatic Solid Tumors × Clear all

NCT07469774 2026-03-13

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors